1401O Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction... von Janjigian, Y.Y., van Laarhoven, H.W.M., Rha, S.Y., Kozlov, V., Oh, D-Y., Gravina, A., Rapatoni, L., Shoji, H., Hofheinz, R.D., Chen, L-T., Ford, H.E.R., Chenard-Poirier, M., Raoufmoghaddam, S., Lloyd, C., Zhang, C., Mateo, C., Lee, J.

Volltext

The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma von Andreopoulou, E., Ross, P. J., O'Brien, M. E. R., Ford, H. E. R., Priest, K., Eisen, T., Norton, A., Ashley, S., Smith, I. E.

Volltext

Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control von Harper-Wynne, C.L., Sumpter, K., Ryan, C., Priest, K., Norton, A., Ross, P., Ford, H.E.R., Johnson, P., O’Brien, M.E.R.

Volltext

Combination of raltitrexed with other cytotoxic agents: rationale and preclinical observations von Jackman, A.L., Kimbell, R., Ford, H.E.R.

Volltext

51 The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer: analy... von Chau, I., Allen, M.J., Cunningham, D., Norman, A.R., Ford, H.E.R., Tebbutt, N., Tait, D., Hill, M., Ross, P.J., Oates, J.

Volltext